BCL2L1 and neoplasm: By quantifying and comparing Bcl-xL expression levels in MPO-positive cells in tumors and tumor-adjacent non-cancerous tissue, we demonstrated that TANs express significantly more Bcl-xL compared to peritumoral neutrophils (Fig. 6B; Appendix Table S1).